Update shared on 12 Dec 2025
Analysts have marginally increased their price target on Jenoptik to approximately $25.56. This reflects slightly higher assumptions for the company’s discount rate and future price to earnings multiple, while maintaining stable growth and margin expectations.
What's in the News
- The supervisory board announces that President and CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, and will leave Jenoptik AG by mutual agreement after nearly nine years in the role (Key Developments).
Valuation Changes
- Fair Value: unchanged at approximately €25.56 per share. This indicates no revision to the central valuation estimate.
- Discount Rate: risen slightly from about 7.08 percent to roughly 7.14 percent. This reflects a modest increase in the assumed cost of capital.
- Revenue Growth: effectively unchanged at around 5.29 percent, with only an immaterial rounding adjustment.
- Net Profit Margin: effectively unchanged at roughly 9.67 percent, indicating stable profitability assumptions.
- Future P/E: risen slightly from about 15.31x to approximately 15.34x. This implies a marginally higher valuation multiple applied to future earnings.
Have other thoughts on Jenoptik?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.